NCT03114462 2026-04-15
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
M.D. Anderson Cancer Center
University of California, San Francisco
University of California, San Francisco